Atrovent
Prevention and treatment of shortness of breath in patients with chronic obstructive pulmonary disease (COPD) and mild to moderate bronchial asthma in adulthood and childhood as a supplement to beta-agonists in cases of acute asthma.
Product Key Facts
Indications
Chronic obstructive pulmonary disease (COPD) Chronic bronchitis Bronchial asthma
Brand Names
Atrovent®
Active ingredients
ipratropium bromide
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
